Trump的2026年保健计划取代了ACA补贴,代之以HSA付款和药物价格改革,引起对中低收入家庭费用增加的关切。 Trump's 2026 healthcare plan replaces ACA subsidies with HSA payments and drug price reforms, raising concerns over cost increases for low- and middle-income families.

2026年1月, 特朗普总统揭幕了他的“大医保计划 ” , 提议以直接支付卫生储蓄账户, 并推行药物定价改革以降低成本, In January 2026, President Trump unveiled his "Great Healthcare Plan," proposing to replace Affordable Care Act subsidies with direct payments into health savings accounts and implementing drug pricing reforms to lower costs. 该计划旨在通过将保险人和药房福利管理人员的资金转用于个人,同时规定价格透明度和限制保险人的权力,从而加强消费者控制。 The plan aims to increase consumer control by redirecting funds from insurers and pharmacy benefit managers to individuals, while mandating price transparency and limiting insurer power. 然而,专家们警告说,这一转变可能会给中低收入家庭带来自付费用,特别是考虑到目前HSA的局限性和供资细节不确定。 However, experts warn the shift could raise out-of-pocket costs for low- and middle-income families, especially given current HSA limitations and uncertain funding details. 该提案缺乏完整的立法案文,其可行性、公平性和对获取机会的影响,特别是对弱势人口而言,将受到仔细审查。 The proposal, lacking full legislative text, faces scrutiny over its feasibility, equity, and impact on access, particularly for vulnerable populations.